Treatment Characteristics and Outcomes for Patients With Rare Forms of T-Cell Lymphoma
Researchers characterized outcomes for enteropathy-associated T-cell lymphoma, hepatosplenic T-cell lymphoma, and peripheral gamma delta T-cell lymphoma.
Diagnosis & Disease Information
CAR-T Therapy May Be Associated With Decreased Utilization of Health Care Resources in Older, “Real-World” Patients With NHL
In this study, claims data from CMS were used to estimate health care utilization of patients with DLCBL before and after CAR-T therapy.
Evidence of Benefit of Mosunetuzumab in Relapsed/Refractory NHL Following CAR-T Cell Therapy
Mosunetuzumab may offer a survival benefit, particularly in patients who have relapsed after the receipt of CAR-T.
Promising First-Line Immunotherapy Findings in Hodgkin Lymphoma: Complete Response of 100%
The study yielded a complete response rate of 100% across 33 subjects.
Corticosteroid-Induced Psychiatric Disorders Are Common in Young Patients With Acute Lymphoblastic Leukemia, Lymphoma
This study addressed the dearth of information on the incidence of psychiatric disorders related to corticosteroid-containing treatment in patients with hematologic malignancies.
Autoimmune Conditions Associated With Primary Central Nervous System Lymphoma
Significant associations were found between primary central nervous system lymphoma and systemic lupus erythematosus, myasthenia gravis, and uveitis.
Discussing Goals of Care With Oncologist, Earlier May Decrease Use of Intensive Health Care at End of Life
Patients with blood cancers were more likely to enroll in hospice earlier if they included a hematologic oncologist in their first discussion about their goals of care.
BAFF-R-CAR-T to Overcome Resistance: Q&A With Dr Hong Qin
It is hypothesized that BAFF-R could prevent the emergence of CD19-based antigen loss.
Physician Experience With Rituximab Affected Rate of Early Discontinuation in NHL
Early discontinuation of rituximab in patients with B-cell non-Hodgkin lymphoma was linked with worse survival.
A Salvage Therapy Option for Follicular Lymphoma Makes Headway
A response‐adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone appeared effective as a salvage therapy for follicular lymphoma.
- Loading...
Loading...
Next post in Lymphoma
Loading... 
Loading...